When treating mice with a PGE2 synthesis inhibitor or TGF-β-specific neutralizing Abs, treated mice showed no reduction in AHR, inflammatory cells in BALF, lung inflammation, asthma-specific cytokines in the BALF and LLN, or serum Th2 immunoglobulins. Here, TGFB1 is linked to asthma.